Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Burkitt Lymphoma 1

Interventions

Rituximab 6Polymerase Chain Reaction 6Amplified Fragment Length Polymorphism Analysis 6Gene Expression Profiling 5obinutuzumab 4Surveys and Questionnaires 4Psychiatric Rehabilitation 4Microarray Analysis 4Immunohistochemistry 4Flow Cytometry 4Therapeutics 3Immunoenzyme Techniques 3Drug Therapy 3tisagenlecleucel 2duvelisib 2Prednisone 2Lenalidomide 2Influenza Vaccines 2Immunologic Techniques 2Echocardiography 2Blood Specimen Collection 2zanubrutinib 1tazemetostat 1relmacabtagene autoleucel 1pomalidomide 1ibritumomab tiuxetan 1deucravacitinib 1Watchful Waiting 1Waiting Lists 1Vincristine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Lymphoma, Follicular × tisagenlecleucel × Clear all
NCT06785818 2026-05-05

Long-term Follow up Local Registry Study of Kymriah in South Korea

Novartis

Recruiting
500 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT05541341 2025-06-06

Effectiveness and Safety of Tisagenlecleucel Therapy in Brazilian Patients With B-lymphocyte Malignancies

Novartis

Recruiting
200 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡